Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

testosterone

testosterone
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Tlando CAPSULE, ORAL 112.5 mg      
Jatenzo CAPSULE, ORAL 158 mg, 198 mg, 237 mg      
Striant FILM, EXTENDED RELEASE, BUCCAL 30 mg/12 hr      
Androderm FILM, EXTENDED RELEASE, TRANSDERMAL 2 mg/24 hrs, 4 mg/24 hrs      
Androderm FILM, EXTENDED RELEASE, TRANSDERMAL 2.5 mg/24 hrs, 5 mg/24 hrs    
Natesto GEL, NASAL 5.5 mg/actuation    
Fortesta GEL, TRANSDERMAL 10 mg/0.5 g    
Vogelxo GEL, TRANSDERMAL 12.5 g/actuation (1%)    
AndroGel Pump GEL, TRANSDERMAL 20.25 mg/actuation (1.62%)    
AndroGel GEL, TRANSDERMAL 25 mg/2.5 g (1%), 50 mg/5 g (1%)      
Testim, Vogelxo GEL, TRANSDERMAL 50 mg/5 g (1%)    
Aveed SOLUTION, INTRAMUSCULAR undecylate 250 mg/mL      
Delatestryl SOLUTION, INTRAMUSCULAR enanthate 200 mg/mL      
Depo-Testosterone SOLUTION, INTRAMUSCULAR cypionate 200 mg/mL      
Xyosted SOLUTION, SUBCUTANEOUS 50 mg/0.5 mL, 75 mg/0.5 mL, 100 mg/0.5 mL      
Axiron SOLUTION, TRANSDERMAL 30 mg/1.5 mL    

VIEW MORE Androgens
CLASS
680800

Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

NOTES

testosterone (Androderm)

  • 2.5 mg patch once Daily
  • 5 mg patch once Daily

testosterone (Androderm)

  • 2 mg patch once Daily*
  • 4 mg patch once Daily*
 

*All strengths of  ANDRODERM patch (2 mg, 2.5 mg, 4 mg, 5 mg) have been removed from the market as of March 2023. 

testosterone (AndroGel Pump)


  • One pump once Daily (Total: 20.25 mg)
  • Two pumps once Daily (Total: 40.5 mg)
  • Three pumps once Daily (Total: 60.75 mg)
  • Four pumps once Daily (Total: 81 mg)                                                                                 
  • Five pumps once Daily (Total: 101.25 mg)

testosterone (AndroGel)


  • ONE 25 mg/2.5 g packet once Daily
  • ONE 50 mg/5 g packet once Daily
  • ONE 50 mg/5 g packet once Daily                         
  • ONE 50 mg/5 g packet PLUS
    ONE 25 mg/2.5 g packet once Daily (Total: 75 mg)
  • TWO 50 mg/5 g packets once Daily (Total: 100 mg)

Give at same dosing interval

 

 

 

 

 

testosterone (Axiron)

  • ONE pump 30 mg/1.5 mL transdermal solution once Daily
  • TWO pumps 30 mg/1.5 mL transdermal solution once Daily (Total: 60 mg)
  • THREE pumps 30 mg/1.5 mL transdermal solution once Daily (Total: 90 mg)
  • FOUR pumps 30 mg/1.5 mL transdermal solution once Daily (Total: 120 mg)

testosterone (AndroGel)

  • ONE 25 mg/2.5 g packet once Daily             
  • ONE 50 mg/5 g packet once                                                        
  • TWO 50 mg/5 g packets once Daily (Total: 100 mg)                
  • TWO 50 mg/5 g packets once Daily (Total: 100 mg)
 

testosterone (Fortesta)

  • 10 mg/0.5 g gel ONE pump
  • 10 mg/0.5 g gel TWO OR THREE pumps (Total: 20 mg or 30 mg)
  • 10 mg/0.5 g gel FOUR, FIVE, or SIX pumps (Total: 40 mg, 50 mg, or 60 mg)
  • 10 mg/0.5 g gel SEVEN or EIGHT pumps (Total: 70 mg or 80 mg)

testosterone (AndroGel)

  • HALF 25 mg/2.5 g packet (Total 12.5 mg)
  • ONE 25 mg/2.5 g packet                                                        
  • ONE 50 mg/5 g packet                                                                               
  • ONE 25 mg/2.5 g packet PLUS ONE 50 mg/5 g packet (Total: 75 mg)
 

testosterone (Natesto)

  • TWO pumps 5.5 mg/actuation gel nasal (Total: 11 mg) TID

testosterone (AndroGel)

  • ONE 50 mg/5 g packet

 

 

testosterone (Testim, Vogelxo)

  • 50 mg/5 g packet

testosterone (AndroGel)

  • ONE 50 mg/5 g packet

 

 Intercahnge on 1 mg: 1 mg testosterone ratio

testosterone (Vogelxo pump)

  • ONE pump 12.5 mg/actuation once Daily                                                   
  • TWO pumps 12.5 mg/actuation once Daily (Total: 25 mg)
  • THREE pumps 12.5 mg/actuation once Daily (Total: 37.5 mg)
  • FOUR pumps 12.5 mg/actuation once Daily (Total: 50 mg)
  • FIVE pumps 12.5 mg/actuation once Daily (Total: 62.5 mg)

testosterone (AndroGEL)

  • HALF 25 mg/2.5 g packet once Daily (Total: 12.5 mg)
  • ONE 25 mg/2.5 g packet once Daily                                
  • ONE 25 mg/2.5 g PLUS HALF 25 mg/2.5 g packet once Daily (Total: 37.5 mg)  
  • 50 mg/5 g packet once Daily                                                                   
  • 50 mg/5 g packets once Daily
 

 


ANDRODERM patches have been discontinued. *Recommend 1% transdermal gel to prescriber. (No automatic interchange as of May 2023)

 

AVEED is classified as non-formulary, not stocked. 

Striant is approved for formulary status, not generally stocked. Usage is expected to be extremely low.

 


Delatestryl : available as an intramuscular (IM) oil, is currently on formulary.

Xyosted : Non-formulary, not stocked and inpatients should use their home supply. Initation of Xyosted should be deferred to the outpatient home setting.

 


DETERRA INFORMATION:

Deterra drug deactivation system is to be used for the disposal of testosterone patches. When a patch is placed inside the pouch and water is added the drug is deactivated. The sealed pouch is then discarded in the regular trash. The Deterra pouch is removed from pyxis by the nurse under the patient's name with a witness. 

Deterra Drug Deactivation Pouch Disposal

Deterra Drug Deactivation Pyxis Removal


Jatenzo & Tlando: Inpatients may use home supply. Recommend alternative products (buccal or transdermal) if prescribed and/or home supply is unavailable.

 


Reviewed: February 28, 2006 (Striant) and April 26, 2011 (AXIRON and FORTESTA) and January 24, 2012 (ANDRODERM patch strengths) and December 16, 2014 (Aveed) and 24 February 2015 (Natesto and Vogelxo) and 23 July 2019 (Xyosted), August 2023 (Jatenzo), Sept 2023 (Tlando)


 
 
REMS(Androgel 1%): View FDA REMS Info
REMS(Androgel 1.62%): View FDA REMS Info
REMS (Aveed): View FDA REMS Info
REMS (Axiron): View FDA REMS Info
REMS (Fortesta): View FDA REMS Info
REMS (Testim): View FDA REMS Info
REMS (Vogelxo): View FDA REMS Info

Last updated: Nov. 6, 2023







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.